HEADER CELL ADHESION 31-MAR-20 6YHW TITLE CO-CRYSTALS IN THE P212121 SPACE GROUP, OF A BETA-CYCLODEXTRIN TITLE 2 SPACERED BY TRIAZOLE HEPTYL FROM ALPHA-D-MANNOSE, WITH FIMH LECTIN AT TITLE 3 2.00 A RESOLUTION. COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIMH; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: FIMH PROTEIN,FIMBRIAL PROTEIN,MINOR COMPONENT OF TYPE 1 COMPND 5 FIMBRIAE,MINOR FIMBRIAL SUBUNIT,D-MANNOSE SPECIFIC ADHESIN,PROTEIN COMPND 6 FIMH,S-FIMBRIAL PROTEIN SUBUNIT SFAH,TYPE 1 FIMBRIA D-MANNOSE COMPND 7 SPECIFIC ADHESIN FIMH,TYPE 1 FIMBRIAL ADHESIN; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 GENE: FIMH, FIMH_1, FIMH_2, FIMH_3, SFAH_2, A6581_19835, SOURCE 5 ACN81_00940, AKG99_10920, AM446_24165, AM464_16260, AUQ13_11280, SOURCE 6 AWG78_008695, B6V57_25500, B9M99_24715, B9T59_08965, BON65_08035, SOURCE 7 BON69_13145, BON76_10045, BON87_19590, BVCMS12BK_05011, SOURCE 8 BVCMS2454_04206, C2U48_10910, C5P44_07835, C6B13_05760, CR538_22045, SOURCE 9 CRX46_08755, D2188_19245, D9G11_20470, D9H70_11375, D9I97_23340, SOURCE 10 D9J60_03345, DJ503_16470, DNQ45_27015, DS732_03965, DU321_25405, SOURCE 11 DXT73_23425, E0L12_19135, EC3234A_192C00060, ECONIH1_25860, SOURCE 12 ECTO6_04155, EIA21_01475, ELV08_23920, EQ830_16720, ERS085383_04267, SOURCE 13 F0312_06085, F1E19_12715, FNJ69_21090, FNJ83_00985, FV293_11400, SOURCE 14 FY127_19655, MS6198_50840, MS8345_04977, NCTC10090_02366, SOURCE 15 NCTC8450_00821, NCTC9045_05036, SAMEA3472056_01232, YDC107_3079; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_VARIANT: C43 KEYWDS BETA-CYCLODEXTRIN HOST-GUEST INTERACTIONS INHIBITOR DESIGN, CELL KEYWDS 2 ADHESION EXPDTA X-RAY DIFFRACTION AUTHOR J.DE RUYCK,J.BOUCKAERT REVDAT 4 24-JAN-24 6YHW 1 REMARK REVDAT 3 13-JAN-21 6YHW 1 JRNL HETSYN LINK REVDAT 2 29-JUL-20 6YHW 1 COMPND REMARK HET HETNAM REVDAT 2 2 1 HETSYN FORMUL LINK SITE REVDAT 2 3 1 ATOM REVDAT 1 06-MAY-20 6YHW 0 SPRSDE 06-MAY-20 6YHW 5AB1 JRNL AUTH D.ALVAREZ DORTA,A.SIVIGNON,T.CHALOPIN,T.I.DUMYCH,G.ROOS, JRNL AUTH 2 R.O.BILYY,D.DENIAUD,E.M.KRAMMER,J.DE RUYCK,M.F.LENSINK, JRNL AUTH 3 J.BOUCKAERT,N.BARNICH,S.G.GOUIN JRNL TITL THE ANTIADHESIVE STRATEGY IN CROHN'S DISEASE: ORALLY ACTIVE JRNL TITL 2 MANNOSIDES TO DECOLONIZE PATHOGENIC ESCHERICHIA COLI FROM JRNL TITL 3 THE GUT. JRNL REF CHEMBIOCHEM V. 17 936 2016 JRNL REFN ESSN 1439-7633 JRNL PMID 26946458 JRNL DOI 10.1002/CBIC.201600018 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.BOUCKAERT,Z.LI,C.XAVIER,M.ALMANT,V.CAVELIERS,T.LAHOUTTE, REMARK 1 AUTH 2 S.D.WEEKS,J.KOVENSKY,S.G.GOUIN REMARK 1 TITL HEPTYL A-D-MANNOSIDES GRAFTED ON A B-CYCLODEXTRIN CORE TO REMARK 1 TITL 2 INTERFERE WITH ESCHERICHIA COLI ADHESION: AN IN VIVO REMARK 1 TITL 3 MULTIVALENT EFFECT. REMARK 1 REF CHEMISTRY V. 19 7847 2013 REMARK 1 REFN ISSN 1521-3765 REMARK 1 PMID 23595913 REMARK 1 DOI 10.1002/CHEM.201204015 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.ALVAREZ DORTA,A.SIVIGNON,T.CHALOPIN,T.I.DUMYCH,G.ROOS, REMARK 1 AUTH 2 R.O.BILYY,D.DENIAUD,E.M.KRAMMER,J.DE RUYCK,M.F.LENSINK, REMARK 1 AUTH 3 J.BOUCKAERT,N.BARNICH,S.G.GOUIN REMARK 1 TITL THE ANTIADHESIVE STRATEGY IN CROHN'S DISEASE: ORALLY ACTIVE REMARK 1 TITL 2 MANNOSIDES TO DECOLONIZE PATHOGENIC ESCHERICHIA COLI FROM REMARK 1 TITL 3 THE GUT. REMARK 1 REF CHEMBIOCHEM V. 17 936 2016 REMARK 1 REFN ESSN 1439-7633 REMARK 1 PMID 26946458 REMARK 1 DOI 10.1002/CBIC.201600018 REMARK 1 REFERENCE 3 REMARK 1 AUTH E.M.KRAMMER,J.DE RUYCK,G.ROOS,J.BOUCKAERT,M.F.LENSINK REMARK 1 TITL TARGETING DYNAMICAL BINDING PROCESSES IN THE DESIGN OF REMARK 1 TITL 2 NON-ANTIBIOTIC ANTI-ADHESIVES BY MOLECULAR SIMULATION-THE REMARK 1 TITL 3 EXAMPLE OF FIMH. REMARK 1 REF MOLECULES V. 23 2018 REMARK 1 REFN ESSN 1420-3049 REMARK 1 PMID 29976867 REMARK 1 DOI 10.3390/MOLECULES23071641 REMARK 1 REFERENCE 4 REMARK 1 AUTH A.SIVIGNON,J.BOUCKAERT,J.BERNARD,S.G.GOUIN,N.BARNICH REMARK 1 TITL THE POTENTIAL OF FIMH AS A NOVEL THERAPEUTIC TARGET FOR THE REMARK 1 TITL 2 TREATMENT OF CROHN'S DISEASE. REMARK 1 REF EXPERT OPIN THER TARGETS V. 21 837 2017 REMARK 1 REFN ISSN 1744-7631 REMARK 1 PMID 28762293 REMARK 1 DOI 10.1080/14728222.2017.1363184 REMARK 1 REFERENCE 5 REMARK 1 AUTH J.DE RUYCK,G.ROOS,E.-M.KRAMMER,M.PREVOST,M.F.LENSINK, REMARK 1 AUTH 2 J.BOUCKAERT REMARK 1 TITL CHAPTER 4 MOLECULAR MECHANISMS OF DRUG ACTION: X-RAY REMARK 1 TITL 2 CRYSTALLOGRAPHY AT THE BASIS OF STRUCTURE-BASED AND REMARK 1 TITL 3 LIGAND-BASED DRUG DESIGN REMARK 1 REF BIOPHYSICAL TECHNIQUES IN 67 2018 REMARK 1 REF 2 DRUG DISCOVERY REMARK 1 PUBL THE ROYAL SOCIETY OF CHEMISTRY REMARK 1 REFN REMARK 1 DOI 10.1039/9781788010016 REMARK 2 REMARK 2 RESOLUTION. 1.96 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.96 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.35 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 26630 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1514 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 2.0250 - 1.9620 0.97 2498 0 0.2991 0.3462 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.910 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.38 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2684 REMARK 3 ANGLE : 0.861 3710 REMARK 3 CHIRALITY : 0.052 478 REMARK 3 PLANARITY : 0.006 444 REMARK 3 DIHEDRAL : 10.858 1008 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6YHW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-MAR-20. REMARK 100 THE DEPOSITION ID IS D_1292107619. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-NOV-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : LIQUID NITROGEN COOLED CHANNEL REMARK 200 -CUT SILICON MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29988 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.962 REMARK 200 RESOLUTION RANGE LOW (A) : 48.348 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.96 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.66700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1UWF REMARK 200 REMARK 200 REMARK: LARGE BARS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 24.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: FIMH (10 MG/ML) WITH BETA-CYCLODEXTRIN REMARK 280 TRIAZOLE HEPTYL A-D-MANNOSE (2 MM). CRYSTALS WERE EQUILIBRATED REMARK 280 AGAINST A WELL CONTAINING SODIUM CITRATE TRIBASIC DIHYDRATE REMARK 280 BUFFER (PH 6.5, 1.6M). PRIOR TO DATA COLLECTION, CRYSTALS WERE REMARK 280 CRYOPROTECTED WITH USE OF RESERVOIR SOLUTION CONTAINING GLYCEROL REMARK 280 (20%) AND FLASH-COOLED IN LIQUID NITROGEN., VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.64100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.88850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.03600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.88850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.64100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.03600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -20 REMARK 465 LYS A -19 REMARK 465 ARG A -18 REMARK 465 VAL A -17 REMARK 465 ILE A -16 REMARK 465 THR A -15 REMARK 465 LEU A -14 REMARK 465 PHE A -13 REMARK 465 ALA A -12 REMARK 465 VAL A -11 REMARK 465 LEU A -10 REMARK 465 LEU A -9 REMARK 465 MET A -8 REMARK 465 GLY A -7 REMARK 465 TRP A -6 REMARK 465 SER A -5 REMARK 465 VAL A -4 REMARK 465 ASN A -3 REMARK 465 ALA A -2 REMARK 465 TRP A -1 REMARK 465 SER A 0 REMARK 465 GLY A 160 REMARK 465 CYS A 161 REMARK 465 ASP A 162 REMARK 465 VAL A 163 REMARK 465 SER A 164 REMARK 465 ALA A 165 REMARK 465 ARG A 166 REMARK 465 ASP A 167 REMARK 465 VAL A 168 REMARK 465 THR A 169 REMARK 465 VAL A 170 REMARK 465 THR A 171 REMARK 465 LEU A 172 REMARK 465 PRO A 173 REMARK 465 ASP A 174 REMARK 465 TYR A 175 REMARK 465 PRO A 176 REMARK 465 GLY A 177 REMARK 465 SER A 178 REMARK 465 VAL A 179 REMARK 465 PRO A 180 REMARK 465 ILE A 181 REMARK 465 PRO A 182 REMARK 465 LEU A 183 REMARK 465 THR A 184 REMARK 465 VAL A 185 REMARK 465 TYR A 186 REMARK 465 CYS A 187 REMARK 465 ALA A 188 REMARK 465 LYS A 189 REMARK 465 SER A 190 REMARK 465 GLN A 191 REMARK 465 ASN A 192 REMARK 465 LEU A 193 REMARK 465 GLY A 194 REMARK 465 TYR A 195 REMARK 465 TYR A 196 REMARK 465 LEU A 197 REMARK 465 SER A 198 REMARK 465 GLY A 199 REMARK 465 THR A 200 REMARK 465 THR A 201 REMARK 465 ALA A 202 REMARK 465 ASP A 203 REMARK 465 ALA A 204 REMARK 465 GLY A 205 REMARK 465 ASN A 206 REMARK 465 SER A 207 REMARK 465 ILE A 208 REMARK 465 PHE A 209 REMARK 465 THR A 210 REMARK 465 ASN A 211 REMARK 465 THR A 212 REMARK 465 ALA A 213 REMARK 465 SER A 214 REMARK 465 PHE A 215 REMARK 465 SER A 216 REMARK 465 PRO A 217 REMARK 465 ALA A 218 REMARK 465 GLN A 219 REMARK 465 GLY A 220 REMARK 465 VAL A 221 REMARK 465 GLY A 222 REMARK 465 VAL A 223 REMARK 465 GLN A 224 REMARK 465 LEU A 225 REMARK 465 THR A 226 REMARK 465 ARG A 227 REMARK 465 ASN A 228 REMARK 465 GLY A 229 REMARK 465 THR A 230 REMARK 465 ILE A 231 REMARK 465 ILE A 232 REMARK 465 PRO A 233 REMARK 465 ALA A 234 REMARK 465 ASN A 235 REMARK 465 ASN A 236 REMARK 465 THR A 237 REMARK 465 VAL A 238 REMARK 465 SER A 239 REMARK 465 LEU A 240 REMARK 465 GLY A 241 REMARK 465 ALA A 242 REMARK 465 VAL A 243 REMARK 465 GLY A 244 REMARK 465 THR A 245 REMARK 465 SER A 246 REMARK 465 ALA A 247 REMARK 465 VAL A 248 REMARK 465 SER A 249 REMARK 465 LEU A 250 REMARK 465 GLY A 251 REMARK 465 LEU A 252 REMARK 465 THR A 253 REMARK 465 ALA A 254 REMARK 465 ASN A 255 REMARK 465 TYR A 256 REMARK 465 ALA A 257 REMARK 465 ARG A 258 REMARK 465 THR A 259 REMARK 465 GLY A 260 REMARK 465 GLY A 261 REMARK 465 GLN A 262 REMARK 465 VAL A 263 REMARK 465 THR A 264 REMARK 465 ALA A 265 REMARK 465 GLY A 266 REMARK 465 ASN A 267 REMARK 465 VAL A 268 REMARK 465 GLN A 269 REMARK 465 SER A 270 REMARK 465 ILE A 271 REMARK 465 ILE A 272 REMARK 465 GLY A 273 REMARK 465 VAL A 274 REMARK 465 THR A 275 REMARK 465 PHE A 276 REMARK 465 VAL A 277 REMARK 465 TYR A 278 REMARK 465 GLN A 279 REMARK 465 MET B -20 REMARK 465 LYS B -19 REMARK 465 ARG B -18 REMARK 465 VAL B -17 REMARK 465 ILE B -16 REMARK 465 THR B -15 REMARK 465 LEU B -14 REMARK 465 PHE B -13 REMARK 465 ALA B -12 REMARK 465 VAL B -11 REMARK 465 LEU B -10 REMARK 465 LEU B -9 REMARK 465 MET B -8 REMARK 465 GLY B -7 REMARK 465 TRP B -6 REMARK 465 SER B -5 REMARK 465 VAL B -4 REMARK 465 ASN B -3 REMARK 465 ALA B -2 REMARK 465 TRP B -1 REMARK 465 SER B 0 REMARK 465 GLY B 160 REMARK 465 CYS B 161 REMARK 465 ASP B 162 REMARK 465 VAL B 163 REMARK 465 SER B 164 REMARK 465 ALA B 165 REMARK 465 ARG B 166 REMARK 465 ASP B 167 REMARK 465 VAL B 168 REMARK 465 THR B 169 REMARK 465 VAL B 170 REMARK 465 THR B 171 REMARK 465 LEU B 172 REMARK 465 PRO B 173 REMARK 465 ASP B 174 REMARK 465 TYR B 175 REMARK 465 PRO B 176 REMARK 465 GLY B 177 REMARK 465 SER B 178 REMARK 465 VAL B 179 REMARK 465 PRO B 180 REMARK 465 ILE B 181 REMARK 465 PRO B 182 REMARK 465 LEU B 183 REMARK 465 THR B 184 REMARK 465 VAL B 185 REMARK 465 TYR B 186 REMARK 465 CYS B 187 REMARK 465 ALA B 188 REMARK 465 LYS B 189 REMARK 465 SER B 190 REMARK 465 GLN B 191 REMARK 465 ASN B 192 REMARK 465 LEU B 193 REMARK 465 GLY B 194 REMARK 465 TYR B 195 REMARK 465 TYR B 196 REMARK 465 LEU B 197 REMARK 465 SER B 198 REMARK 465 GLY B 199 REMARK 465 THR B 200 REMARK 465 THR B 201 REMARK 465 ALA B 202 REMARK 465 ASP B 203 REMARK 465 ALA B 204 REMARK 465 GLY B 205 REMARK 465 ASN B 206 REMARK 465 SER B 207 REMARK 465 ILE B 208 REMARK 465 PHE B 209 REMARK 465 THR B 210 REMARK 465 ASN B 211 REMARK 465 THR B 212 REMARK 465 ALA B 213 REMARK 465 SER B 214 REMARK 465 PHE B 215 REMARK 465 SER B 216 REMARK 465 PRO B 217 REMARK 465 ALA B 218 REMARK 465 GLN B 219 REMARK 465 GLY B 220 REMARK 465 VAL B 221 REMARK 465 GLY B 222 REMARK 465 VAL B 223 REMARK 465 GLN B 224 REMARK 465 LEU B 225 REMARK 465 THR B 226 REMARK 465 ARG B 227 REMARK 465 ASN B 228 REMARK 465 GLY B 229 REMARK 465 THR B 230 REMARK 465 ILE B 231 REMARK 465 ILE B 232 REMARK 465 PRO B 233 REMARK 465 ALA B 234 REMARK 465 ASN B 235 REMARK 465 ASN B 236 REMARK 465 THR B 237 REMARK 465 VAL B 238 REMARK 465 SER B 239 REMARK 465 LEU B 240 REMARK 465 GLY B 241 REMARK 465 ALA B 242 REMARK 465 VAL B 243 REMARK 465 GLY B 244 REMARK 465 THR B 245 REMARK 465 SER B 246 REMARK 465 ALA B 247 REMARK 465 VAL B 248 REMARK 465 SER B 249 REMARK 465 LEU B 250 REMARK 465 GLY B 251 REMARK 465 LEU B 252 REMARK 465 THR B 253 REMARK 465 ALA B 254 REMARK 465 ASN B 255 REMARK 465 TYR B 256 REMARK 465 ALA B 257 REMARK 465 ARG B 258 REMARK 465 THR B 259 REMARK 465 GLY B 260 REMARK 465 GLY B 261 REMARK 465 GLN B 262 REMARK 465 VAL B 263 REMARK 465 THR B 264 REMARK 465 ALA B 265 REMARK 465 GLY B 266 REMARK 465 ASN B 267 REMARK 465 VAL B 268 REMARK 465 GLN B 269 REMARK 465 SER B 270 REMARK 465 ILE B 271 REMARK 465 ILE B 272 REMARK 465 GLY B 273 REMARK 465 VAL B 274 REMARK 465 THR B 275 REMARK 465 PHE B 276 REMARK 465 VAL B 277 REMARK 465 TYR B 278 REMARK 465 GLN B 279 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLY A 159 CA C O REMARK 470 GLY B 159 CA C O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H201 HP6 A 503 O1 MAN A 504 0.64 REMARK 500 H202 HP6 B 503 O1 MAN B 504 0.93 REMARK 500 OG TA5 A 502 H262 HP6 A 503 1.21 REMARK 500 OG TA5 A 502 H261 HP6 A 503 1.56 REMARK 500 HO3 GLC D 1 O2 GLC D 2 1.58 REMARK 500 O3 GLC C 5 O HOH A 601 1.90 REMARK 500 O HOH B 638 O HOH B 706 1.92 REMARK 500 O3 GLC D 5 O2 GLC D 6 1.94 REMARK 500 C6 GLC D 2 N2 TA5 B 502 1.96 REMARK 500 O HOH A 726 O HOH A 767 2.02 REMARK 500 O HOH B 710 O HOH B 736 2.04 REMARK 500 O HOH A 613 O HOH A 723 2.06 REMARK 500 O HOH A 683 O HOH A 727 2.06 REMARK 500 O HOH B 602 O HOH B 760 2.09 REMARK 500 O HOH A 649 O HOH A 716 2.09 REMARK 500 O6 GLC D 3 O HOH B 601 2.10 REMARK 500 O HOH A 721 O HOH A 755 2.11 REMARK 500 O HOH A 738 O HOH A 739 2.16 REMARK 500 O HOH B 727 O HOH B 739 2.17 REMARK 500 OG TA5 A 502 C25 HP6 A 503 2.17 REMARK 500 O HOH B 602 O HOH B 638 2.19 REMARK 500 O HOH A 624 O HOH A 719 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 748 O HOH B 755 4478 1.88 REMARK 500 O HOH A 763 O HOH B 737 4478 1.89 REMARK 500 O HOH A 756 O HOH B 755 4478 1.92 REMARK 500 O HOH B 704 O HOH B 715 2675 2.01 REMARK 500 O HOH A 700 O HOH B 636 2574 2.04 REMARK 500 NZ LYS A 121 O3 GLC D 3 1554 2.06 REMARK 500 OH TYR B 149 O3 GLC C 4 1655 2.06 REMARK 500 O HOH A 732 O HOH B 670 2574 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 48 51.07 -145.13 REMARK 500 TYR A 137 -51.93 -121.83 REMARK 500 ASN A 138 -153.10 -138.01 REMARK 500 ASN B 7 -156.64 92.59 REMARK 500 TYR B 48 51.17 -144.41 REMARK 500 ASN B 138 -152.04 -137.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 779 DISTANCE = 6.00 ANGSTROMS REMARK 525 HOH A 780 DISTANCE = 6.34 ANGSTROMS REMARK 525 HOH B 770 DISTANCE = 6.36 ANGSTROMS DBREF 6YHW A -20 279 UNP Q6JKW3 Q6JKW3_ECOLX 1 300 DBREF 6YHW B -20 279 UNP Q6JKW3 Q6JKW3_ECOLX 1 300 SEQRES 1 A 300 MET LYS ARG VAL ILE THR LEU PHE ALA VAL LEU LEU MET SEQRES 2 A 300 GLY TRP SER VAL ASN ALA TRP SER PHE ALA CYS LYS THR SEQRES 3 A 300 ALA ASN GLY THR ALA ILE PRO ILE GLY GLY GLY SER ALA SEQRES 4 A 300 ASN VAL TYR VAL ASN LEU ALA PRO VAL VAL ASN VAL GLY SEQRES 5 A 300 GLN ASN LEU VAL VAL ASP LEU SER THR GLN ILE PHE CYS SEQRES 6 A 300 HIS ASN ASP TYR PRO GLU THR ILE THR ASP TYR VAL THR SEQRES 7 A 300 LEU GLN ARG GLY SER ALA TYR GLY GLY VAL LEU SER ASN SEQRES 8 A 300 PHE SER GLY THR VAL LYS TYR SER GLY SER SER TYR PRO SEQRES 9 A 300 PHE PRO THR THR SER GLU THR PRO ARG VAL VAL TYR ASN SEQRES 10 A 300 SER ARG THR ASP LYS PRO TRP PRO VAL ALA LEU TYR LEU SEQRES 11 A 300 THR PRO VAL SER SER ALA GLY GLY VAL ALA ILE LYS ALA SEQRES 12 A 300 GLY SER LEU ILE ALA VAL LEU ILE LEU ARG GLN THR ASN SEQRES 13 A 300 ASN TYR ASN SER ASP ASP PHE GLN PHE VAL TRP ASN ILE SEQRES 14 A 300 TYR ALA ASN ASN ASP VAL VAL VAL PRO THR GLY GLY CYS SEQRES 15 A 300 ASP VAL SER ALA ARG ASP VAL THR VAL THR LEU PRO ASP SEQRES 16 A 300 TYR PRO GLY SER VAL PRO ILE PRO LEU THR VAL TYR CYS SEQRES 17 A 300 ALA LYS SER GLN ASN LEU GLY TYR TYR LEU SER GLY THR SEQRES 18 A 300 THR ALA ASP ALA GLY ASN SER ILE PHE THR ASN THR ALA SEQRES 19 A 300 SER PHE SER PRO ALA GLN GLY VAL GLY VAL GLN LEU THR SEQRES 20 A 300 ARG ASN GLY THR ILE ILE PRO ALA ASN ASN THR VAL SER SEQRES 21 A 300 LEU GLY ALA VAL GLY THR SER ALA VAL SER LEU GLY LEU SEQRES 22 A 300 THR ALA ASN TYR ALA ARG THR GLY GLY GLN VAL THR ALA SEQRES 23 A 300 GLY ASN VAL GLN SER ILE ILE GLY VAL THR PHE VAL TYR SEQRES 24 A 300 GLN SEQRES 1 B 300 MET LYS ARG VAL ILE THR LEU PHE ALA VAL LEU LEU MET SEQRES 2 B 300 GLY TRP SER VAL ASN ALA TRP SER PHE ALA CYS LYS THR SEQRES 3 B 300 ALA ASN GLY THR ALA ILE PRO ILE GLY GLY GLY SER ALA SEQRES 4 B 300 ASN VAL TYR VAL ASN LEU ALA PRO VAL VAL ASN VAL GLY SEQRES 5 B 300 GLN ASN LEU VAL VAL ASP LEU SER THR GLN ILE PHE CYS SEQRES 6 B 300 HIS ASN ASP TYR PRO GLU THR ILE THR ASP TYR VAL THR SEQRES 7 B 300 LEU GLN ARG GLY SER ALA TYR GLY GLY VAL LEU SER ASN SEQRES 8 B 300 PHE SER GLY THR VAL LYS TYR SER GLY SER SER TYR PRO SEQRES 9 B 300 PHE PRO THR THR SER GLU THR PRO ARG VAL VAL TYR ASN SEQRES 10 B 300 SER ARG THR ASP LYS PRO TRP PRO VAL ALA LEU TYR LEU SEQRES 11 B 300 THR PRO VAL SER SER ALA GLY GLY VAL ALA ILE LYS ALA SEQRES 12 B 300 GLY SER LEU ILE ALA VAL LEU ILE LEU ARG GLN THR ASN SEQRES 13 B 300 ASN TYR ASN SER ASP ASP PHE GLN PHE VAL TRP ASN ILE SEQRES 14 B 300 TYR ALA ASN ASN ASP VAL VAL VAL PRO THR GLY GLY CYS SEQRES 15 B 300 ASP VAL SER ALA ARG ASP VAL THR VAL THR LEU PRO ASP SEQRES 16 B 300 TYR PRO GLY SER VAL PRO ILE PRO LEU THR VAL TYR CYS SEQRES 17 B 300 ALA LYS SER GLN ASN LEU GLY TYR TYR LEU SER GLY THR SEQRES 18 B 300 THR ALA ASP ALA GLY ASN SER ILE PHE THR ASN THR ALA SEQRES 19 B 300 SER PHE SER PRO ALA GLN GLY VAL GLY VAL GLN LEU THR SEQRES 20 B 300 ARG ASN GLY THR ILE ILE PRO ALA ASN ASN THR VAL SER SEQRES 21 B 300 LEU GLY ALA VAL GLY THR SER ALA VAL SER LEU GLY LEU SEQRES 22 B 300 THR ALA ASN TYR ALA ARG THR GLY GLY GLN VAL THR ALA SEQRES 23 B 300 GLY ASN VAL GLN SER ILE ILE GLY VAL THR PHE VAL TYR SEQRES 24 B 300 GLN HET GLC C 1 21 HET GLC C 2 19 HET GLC C 3 21 HET GLC C 4 21 HET GLC C 5 21 HET GLC C 6 21 HET GLC C 7 21 HET GLC D 1 21 HET GLC D 2 19 HET GLC D 3 21 HET GLC D 4 21 HET GLC D 5 21 HET GLC D 6 21 HET GLC D 7 21 HET TA5 A 502 12 HET HP6 A 503 23 HET MAN A 504 24 HET TA5 B 502 12 HET HP6 B 503 23 HET MAN B 504 24 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM TA5 2H-1,2,3-TRIAZOL-4-YLMETHANOL HETNAM HP6 HEPTANE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 3 GLC 14(C6 H12 O6) FORMUL 5 TA5 2(C3 H5 N3 O) FORMUL 6 HP6 2(C7 H16) FORMUL 7 MAN 2(C6 H12 O6) FORMUL 11 HOH *350(H2 O) HELIX 1 AA1 TYR A 64 ASN A 70 1 7 HELIX 2 AA2 TYR B 64 ASN B 70 1 7 SHEET 1 AA1 4 ALA A 10 ILE A 11 0 SHEET 2 AA1 4 ALA A 2 THR A 5 -1 N CYS A 3 O ILE A 11 SHEET 3 AA1 4 ILE A 42 HIS A 45 -1 O PHE A 43 N LYS A 4 SHEET 4 AA1 4 LYS A 101 PRO A 102 -1 O LYS A 101 N CYS A 44 SHEET 1 AA2 5 GLY A 16 VAL A 22 0 SHEET 2 AA2 5 PHE A 142 ALA A 150 1 O TYR A 149 N VAL A 20 SHEET 3 AA2 5 LEU A 125 ASN A 135 -1 N ALA A 127 O ILE A 148 SHEET 4 AA2 5 ASP A 54 ALA A 63 -1 N ARG A 60 O ILE A 130 SHEET 5 AA2 5 VAL A 93 TYR A 95 -1 O VAL A 93 N VAL A 56 SHEET 1 AA3 4 LEU A 34 ASP A 37 0 SHEET 2 AA3 4 VAL A 105 PRO A 111 -1 O LEU A 109 N LEU A 34 SHEET 3 AA3 4 PHE A 71 TYR A 77 -1 N LYS A 76 O ALA A 106 SHEET 4 AA3 4 SER A 80 PHE A 84 -1 O SER A 80 N TYR A 77 SHEET 1 AA4 2 GLY A 117 ILE A 120 0 SHEET 2 AA4 2 VAL A 154 VAL A 156 -1 O VAL A 156 N GLY A 117 SHEET 1 AA5 4 ALA B 10 ILE B 11 0 SHEET 2 AA5 4 ALA B 2 THR B 5 -1 N CYS B 3 O ILE B 11 SHEET 3 AA5 4 ILE B 42 HIS B 45 -1 O PHE B 43 N LYS B 4 SHEET 4 AA5 4 LYS B 101 PRO B 102 -1 O LYS B 101 N CYS B 44 SHEET 1 AA6 5 GLY B 16 VAL B 22 0 SHEET 2 AA6 5 PHE B 142 ALA B 150 1 O TYR B 149 N VAL B 20 SHEET 3 AA6 5 LEU B 125 ASN B 135 -1 N LEU B 131 O PHE B 144 SHEET 4 AA6 5 ASP B 54 ALA B 63 -1 N TYR B 55 O THR B 134 SHEET 5 AA6 5 VAL B 93 TYR B 95 -1 O VAL B 93 N VAL B 56 SHEET 1 AA7 4 LEU B 34 ASP B 37 0 SHEET 2 AA7 4 VAL B 105 PRO B 111 -1 O LEU B 109 N LEU B 34 SHEET 3 AA7 4 PHE B 71 TYR B 77 -1 N LYS B 76 O ALA B 106 SHEET 4 AA7 4 SER B 80 PHE B 84 -1 O SER B 80 N TYR B 77 SHEET 1 AA8 2 GLY B 117 ILE B 120 0 SHEET 2 AA8 2 VAL B 154 VAL B 156 -1 O VAL B 156 N GLY B 117 SSBOND 1 CYS A 3 CYS A 44 1555 1555 2.04 LINK OG TA5 A 502 C26 HP6 A 503 1555 1555 1.54 LINK NT TA5 A 502 C6 GLC C 2 1555 1555 1.55 LINK C20 HP6 A 503 O1 MAN A 504 1555 1555 1.59 LINK OG TA5 B 502 C26 HP6 B 503 1555 1555 1.50 LINK NT TA5 B 502 C6 GLC D 2 1555 1555 1.59 LINK C20 HP6 B 503 O1 MAN B 504 1555 1555 1.53 LINK O4 GLC C 1 C1 GLC C 2 1555 1555 1.41 LINK C1 GLC C 1 O4 GLC C 7 1555 1555 1.41 LINK O4 GLC C 2 C1 GLC C 3 1555 1555 1.41 LINK O4 GLC C 3 C1 GLC C 4 1555 1555 1.42 LINK O4 GLC C 4 C1 GLC C 5 1555 1555 1.41 LINK O4 GLC C 5 C1 GLC C 6 1555 1555 1.41 LINK O4 GLC C 6 C1 GLC C 7 1555 1555 1.41 LINK O4 GLC D 1 C1 GLC D 2 1555 1555 1.41 LINK C1 GLC D 1 O4 GLC D 7 1555 1555 1.41 LINK O4 GLC D 2 C1 GLC D 3 1555 1555 1.41 LINK O4 GLC D 3 C1 GLC D 4 1555 1555 1.41 LINK O4 GLC D 4 C1 GLC D 5 1555 1555 1.42 LINK O4 GLC D 5 C1 GLC D 6 1555 1555 1.41 LINK O4 GLC D 6 C1 GLC D 7 1555 1555 1.41 CISPEP 1 PHE A 84 PRO A 85 0 -1.11 CISPEP 2 PHE B 84 PRO B 85 0 0.53 CRYST1 63.282 68.072 95.777 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015802 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014690 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010441 0.00000